770
Participants
Start Date
February 15, 2019
Primary Completion Date
January 20, 2022
Study Completion Date
July 3, 2023
Durvalumab
IV infusion every 4 weeks
Cisplatin
Platinum based Standard of Care Chemotherapy administered concurrent with radiation therapy
Carboplatin
For patients enrolled under CSP v2 and prior - platinum based Standard of Care Chemotherapy administered concurrent with radiation therapy
external beam radiation therapy (EBRT) + brachytherapy
Radiation therapy per standard of care
Research Site, Taoyuan
Research Site, Tainan City
Research Site, Manila
Research Site, Quezon City
Research Site, Budapest
Research Site, Makati
Research Site, Parktown
Research Site, Baguio City
Research Site, Debrecen
Research Site, Iloilo City
Research Site, Cebu
Research Site, Port Elizabeth
Research Site, Szeged
Research Site, Kaposvár
Research Site, Győr
Research Site, Taipei
Research Site, Taipei
Research Site, The Bronx
Research Site, Lake Success
Research Site, Taipei
Research Site, Taipei
Research Site, Deleg. Tlalpan
Research Site, Augusta
Research Site, Miami
Research Site, Fort Myers
Research Site, Nashville
Research Site, Taichung
Research Site, Cleveland
Research Site, Cleveland
Research Site, Cleveland
Research Site, Guadalajara Jalisco
Research Site, Guadalajara
Research Site, Ann Arbor
Research Site, Dallas
Research Site, Dallas
Research Site, Spring
Research Site, San Luis Potosí City
Research Site, Phoenix
Research Site, Veracruz
Research Site, La Jolla
Research Site, Orange
Research Site, Mérida
Research Site, Shenyang
Research Site, Shenyang
Research Site, New Delhi
Research Site, Moscow
Research Site, Moscow
Research Site, Gūrgaon
Research Site, Moscow
Research Site, Changchun
Research Site, Arkhangelsk
Research Site, Shanghai
Research Site, Hefei
Research Site, Hefei
Research Site, Kaluga
Research Site, Tianjin
Research Site, Hangzhou
Research Site, Ahmedabad
Research Site, Mumbai
Research Site, Chongqing
Research Site, Changsha
Research Site, Nashik
Research Site, Wuhan
Research Site, Wuhan
Research Site, Nagpur
Research Site, Chelyabinsk
Research Site, Guangzhou
Research Site, Visakhapatnam
Research Site, Chengdu
Research Site, Madurai
Research Site, Novosibirsk
Research Site, Antofagasta
Research Site, Viña del Mar
Research Site, Temuco
Research Site, Temuco
Research Site, Santiago
Research Site, Santiago
Research Site, Santiago
Research Site, Barretos
Research Site, Fortaleza
Research Site, Londrina
Research Site, Porto Alegre
Research Site, Porto Alegre
Research Site, Porto Alegre
Research Site, Porto Alegre
Research Site, Rio de Janeiro
Research Site, São José do Rio Preto
Research Site, São Paulo
Research Site, São Paulo
Research Site, São Paulo
Research Site, São Paulo
Research Site, Fukuoka
Research Site, Kagoshima
Research Site, Kōtoku
Research Site, Kyoto
Research Site, Nakagami-gun
Research Site, Osaka
Research Site, Sapporo
Research Site, Sendai
Research Site, Shinjuku-ku
Research Site, Toon-shi
Research Site, Yokohama
Research Site, Alc. Cuauhtémoc
Research Site, Lima
Research Site, Lima
Research Site, Lima
Research Site, Lima
Research Site, Lima
Research Site, Bialystok
Research Site, Gdansk
Research Site, Gliwice
Research Site, Lodz
Research Site, Lublin
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Lead Sponsor
AstraZeneca
INDUSTRY